Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies
Michael E. Lidsky(Duke University), Kris C. Wood(Duke University), Shannon J. McCall(Duke Medical Center), Zhecheng Sheng(Duke University), Karen S. Anderson(Arizona State University), Joshua A. Granek(Duke University), Zechen Wang(Guangdong University of Petrochemical Technology), Annie Liu(Duke University), David S. Hsu(Duke University), Min Lu(South China Agricultural University), Kouros Owzar(Duke University)
Cited by 17
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
|Hepatology|2007|1k
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34 <sup>+</sup> Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
|Science Translational Medicine|2010|376